Abnormal glycosylation with hypersialylated O-glycans in patients with Sialuria

Suzan Wopereis, Umi M. Abd Hamid, Alison Critchley, Louise Royle, Raymond A. Dwek, Éva Morava, Jules G. Leroy, Bridget Wilcken, Aart J. Lagerwerf, Karin M.L.C. Huijben, Dirk J. Lefeber, Pauline M. Rudd, Ron A. Wevers

Research output: Contribution to journalArticle

19 Scopus citations

Abstract

Sialuria is an inborn error of metabolism characterized by coarse face, hepatomegaly and recurrent respiratory tract infections. The genetic defect in this disorder results in a loss of feedback control of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine-kinase by CMP-N-acetylneuraminic acid (CMP-NeuAc) resulting in a substantial overproduction of cytoplasmic free sialic acid. This study addresses fibroblast CMP-NeuAc levels and N- and O-glycan sialylation of serum proteins from Sialuria patients. CMP-NeuAc levels were measured with HPLC in fibroblasts. Isoelectric focusing (IEF) of serum transferrin and of apolipoprotein C-III (apoC-III) was performed on serum of three Sialuria patients. Isoforms of these proteins can be used as specific markers for the biosynthesis of N- and core 1 O-glycans. Furthermore, total N- and O-linked glycans from serum proteins were analyzed by HPLC. HPLC showed a clear overproduction of CMP-NeuAc in fibroblasts of a Sialuria patient. Minor changes were found for serum N-glycans and hypersialylation was found for core 1 O-glycans on serum apoC-III and on total serum O-glycans in Sialuria patients. HPLC showed an increased ratio of disialylated over monosialylated core 1 O-glycans. The hypersialylation of core 1 O-glycans is due to the increase of NeuAcα2,6-containing structures (mainly NeuAcα2-3Galβ1-3[NeuAcα2-6]GalNAc). This may relate to KM differences between GalNAc-α2,6-sialyltransferase and α2,3-sialyltransferases. This is the first study demonstrating that the genetic defect in Sialuria results in a CMP-NeuAc overproduction. Subsequently, increased amounts of α2,6-linked NeuAc were found on serum core 1 O-glycans from Sialuria patients. N-glycosylation of serum proteins seems largely unaffected. Sialuria is the first metabolic disorder presenting with hypersialylated O-glycans.

Original languageEnglish (US)
Pages (from-to)598-607
Number of pages10
JournalBiochimica et Biophysica Acta - Molecular Basis of Disease
Volume1762
Issue number6
DOIs
StatePublished - Jun 1 2006

Keywords

  • Core I O-glycans
  • Hypersialylation
  • N-glycosylation
  • O-glycosylation, Sialuria OMIM 269921

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology

Fingerprint Dive into the research topics of 'Abnormal glycosylation with hypersialylated O-glycans in patients with Sialuria'. Together they form a unique fingerprint.

  • Cite this

    Wopereis, S., Abd Hamid, U. M., Critchley, A., Royle, L., Dwek, R. A., Morava, É., Leroy, J. G., Wilcken, B., Lagerwerf, A. J., Huijben, K. M. L. C., Lefeber, D. J., Rudd, P. M., & Wevers, R. A. (2006). Abnormal glycosylation with hypersialylated O-glycans in patients with Sialuria. Biochimica et Biophysica Acta - Molecular Basis of Disease, 1762(6), 598-607. https://doi.org/10.1016/j.bbadis.2006.03.009